Literature DB >> 22505639

Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.

Donald D Smith1, Xiaoyu Tan, Vineesh V Raveendran, Ossama Tawfik, Daniel J Stechschulte, Kottarappat N Dileepan.   

Abstract

Mast cells are important cells of the immune system and are recognized as participants in the pathogenesis of atherosclerosis. In this study, we evaluated the role of mast cells on the progression of atherosclerosis and hepatic steatosis using the apolipoprotein E-deficient (ApoE(-/-)) and ApoE(-/-)/mast cell-deficient (Kit(W-sh/W-sh)) mouse models maintained on a high-fat diet. The en face analyses of aortas showed a marked reduction in plaque coverage in ApoE(-/-)/Kit(W-sh/W-sh) compared with ApoE(-/-) after a 6-mo regimen with no significant change noted after 3 mo. Quantification of intima/media thickness on hematoxylin and eosin-stained histological cross sections of the aortic arch revealed no significant difference between ApoE(-/-) and ApoE(-/-)/Kit(W-sh/W-sh) mice. The high-fat regimen did not induce atherosclerosis in either Kit(W-sh/W-sh) or wild-type mice. Mast cells with indications of degranulation were seen only in the aortic walls and heart of ApoE(-/-) mice. Compared with ApoE(-/-) mice, the serum levels of total cholesterol, low-density lipoprotein and high-density lipoprotein were decreased by 50% in ApoE(-/-)/Kit(W-sh/W-sh) mice, whereas no appreciable differences were noted in serum levels of triglycerides or very low density lipoprotein. ApoE(-/-)/Kit(W-sh/W-sh) mice developed significantly less hepatic steatosis than ApoE(-/-) mice after the 3-mo regimen. The analysis of Th1/Th2/Th17 cytokine profile in the sera revealed significant reduction of interleukin (IL)-6 and IL-10 in ApoE(-/-)/Kit(W-sh/W-sh) mice compared with ApoE(-/-) mice. The assessment of systemic generation of thromboxane A(2) (TXA(2)) and prostaglandin I(2) (PGI(2)) revealed significant decrease in the production of PGI(2) in ApoE(-/-)/Kit(W-sh/W-sh) mice with no change in TXA(2). The decrease in PGI(2) production was found to be associated with reduced levels of cyclooxygenase-2 mRNA in the aortic tissues. A significant reduction in T-lymphocytes and macrophages was noted in the atheromas of the ApoE(-/-)/Kit(W-sh/W-sh) mice. These results demonstrate the direct involvement of mast cells in the progression of atherosclerosis and hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505639      PMCID: PMC3378258          DOI: 10.1152/ajpheart.00879.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  41 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Innate and adaptive immunity in the pathogenesis of atherosclerosis.

Authors:  Göran K Hansson; Peter Libby; Uwe Schönbeck; Zhong-Qun Yan
Journal:  Circ Res       Date:  2002-08-23       Impact factor: 17.367

3.  Increased adventitial mast cells in a patient with coronary spasm.

Authors:  M B Forman; J A Oates; D Robertson; R M Robertson; L J Roberts; R Virmani
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

4.  Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

Authors:  O Belton; D Byrne; D Kearney; A Leahy; D J Fitzgerald
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

5.  Increased liver mast cells in patients with chronic hepatitis C.

Authors:  Suda Tekin Koruk; Ilyas Ozardali; Dilnur Dincoglu; Muharrem Bitiren
Journal:  Indian J Pathol Microbiol       Date:  2011 Oct-Dec       Impact factor: 0.740

6.  Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm.

Authors:  S Kalsner; R Richards
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

7.  Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.

Authors:  G A FitzGerald; B Smith; A K Pedersen; A R Brash
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

8.  Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.

Authors:  Orina A Belton; Angela Duffy; Sinead Toomey; Desmond J Fitzgerald
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

9.  Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

Authors:  Takuya Kobayashi; Yoshio Tahara; Mayumi Matsumoto; Masako Iguchi; Hideto Sano; Toshinori Murayama; Hidenori Arai; Hiroji Oida; Takami Yurugi-Kobayashi; Jun K Yamashita; Hiroyuki Katagiri; Masataka Majima; Masayuki Yokode; Toru Kita; Shuh Narumiya
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components.

Authors:  Jaya Talreja; Mohammad H Kabir; Michael B Filla; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

View more
  14 in total

1.  Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.

Authors:  Jens De Vos; Iris Mathijs; Catarina Xavier; Sam Massa; Ulrich Wernery; Luc Bouwens; Tony Lahoutte; Serge Muyldermans; Nick Devoogdt
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

2.  H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Authors:  Vineesh V Raveendran; Karen M Kassel; Donald D Smith; James P Luyendyk; Kurt J Williams; Rachel Cherian; Gregory A Reed; Colleen A Flynn; Iván L Csanaky; Andrew L Lickteig; Matthew J Pratt-Hyatt; Curtis D Klaassen; Kottarappat N Dileepan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

Review 3.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 4.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

5.  Diesel Exhaust Induces Mitochondrial Dysfunction, Hyperlipidemia, and Liver Steatosis.

Authors:  Fen Yin; Rajat Gupta; Laurent Vergnes; Will S Driscoll; Jerry Ricks; Gajalakshmi Ramanathan; James A Stewart; Diana M Shih; Kym F Faull; Simon W Beaven; Aldons J Lusis; Karen Reue; Michael E Rosenfeld; Jesús A Araujo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-07-25       Impact factor: 8.311

6.  Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.

Authors:  Jing Wang; Sara Sjöberg; Viviane Tia; Blandine Secco; Han Chen; Min Yang; Galina K Sukhova; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2013-06-07       Impact factor: 5.162

7.  Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.

Authors:  Laura Hargrove; Lindsey Kennedy; Jennifer Demieville; Hannah Jones; Fanyin Meng; Sharon DeMorrow; Walker Karstens; Taronish Madeka; John Greene; Heather Francis
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

Review 8.  Mast cells in liver disease progression: An update on current studies and implications.

Authors:  Linh Pham; Lindsey Kennedy; Leonardo Baiocchi; Vik Meadows; Burcin Ekser; Debjyoti Kundu; Tianhao Zhou; Keisaku Sato; Shannon Glaser; Ludovica Ceci; Gianfranco Alpini; Heather Francis
Journal:  Hepatology       Date:  2021-12-12       Impact factor: 17.298

Review 9.  Interaction between allergic asthma and atherosclerosis.

Authors:  Cong-Lin Liu; Jin-Ying Zhang; Guo-Ping Shi
Journal:  Transl Res       Date:  2015-10-09       Impact factor: 7.012

10.  Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.

Authors:  Lindsey Kennedy; Vik Meadows; Amelia Sybenga; Jennifer Demieville; Lixian Chen; Laura Hargrove; Burcin Ekser; Wasim Dar; Ludovica Ceci; Debjyoti Kundu; Konstantina Kyritsi; Linh Pham; Tianhao Zhou; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Hepatology       Date:  2021-05-24       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.